Clinical Trial Update: QL1706 Plus Chemotherapy With AG Regime as First-line Treatment of Advanced PDAC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating QL1706 with AG chemotherapy as first-line treatment for advanced pancreatic adenocarcinoma. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• QL1706

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Pancreatic Adenocarcinoma | Phase 2 | Status: NOT_YET_RECRUITING